tiprankstipranks
Trending News
More News >
Circassia Pharmaceuticals PLC (CSSPF)
OTHER OTC:CSSPF
US Market
Advertisement

Circassia Pharmaceuticals (CSSPF) Income Statement

Compare
8 Followers

Circassia Pharmaceuticals Income Statement

Last quarter (Q2 2025), Circassia Pharmaceuticals's total revenue was £25.20M, an increase of 62.58% from the same quarter last year. In Q2, Circassia Pharmaceuticals's net income was £5.90M. See Circassia Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 19Dec 18Dec 17Dec 16
Total Revenue
£ 41.80M£ 34.60M£ 48.30M£ 46.30M£ 23.10M
Gross Profit
£ 30.20M£ 25.50M£ 39.40M£ 36.30M£ 15.10M
Operating Expenses
£ 22.50M£ 28.80M£ 95.50M£ 110.90M£ 54.80M
Depreciation and Amortization
£ 4.20M£ 15.20M£ 4.40M£ 4.80M£ 5.20M
EBITDA
£ 12.20M£ -12.30M£ -32.80M£ -69.20M£ -33.40M
Operating Income
£ 7.70M£ -63.80M£ -37.20M£ -36.90M£ -43.80M
Other Income/Expenses
£ 100.00K£ 0.00£ -15.40M£ 8.00M£ 5.00M
Pretax Income
£ 7.80M£ -27.60M£ -55.80M£ -74.20M£ -38.80M
Net Income
£ 3.70M£ -48.30M£ -46.60M£ -60.50M£ -36.80M
Per Share Metrics
Basic EPS
£ 0.01£ -0.13£ -0.14£ -0.19£ -0.13
Diluted EPS
£ 0.01£ -0.13£ -0.14£ -0.19£ -0.13
Weighted Average Shares Outstanding
418.21M 373.70M 344.35M 319.54M 284.89M
Weighted Average Shares Outstanding (Diluted)
448.21M 373.70M 344.35M 319.54M 284.89M
Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis